Dennis M. Flannelly
Direktor/Vorstandsmitglied bei Kenota Health, Inc.
Profil
Dennis M.
Flannelly is currently a Director at Weavr Health Corp., a Director at Kenota Health, Inc. since 2022, and was previously the Head-US Marketing & Strategy at Phadia AB since 2011.
He was also a former Director at ReadCoor, Inc. Flannelly holds a graduate degree from St. Joseph's University and an undergraduate degree from Villanova University.
Aktive Positionen von Dennis M. Flannelly
| Unternehmen | Position | Beginn |
|---|---|---|
Phadia AB
 Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Vertrieb & Marketing | 20.07.2011 |
Weavr Health Corp.
 Weavr Health Corp. Medical DistributorsDistribution Services Boston MicroFluidics, Inc. manufactures medical devices. Its product is designed to measure, prepare, and transport blood samples. The company was founded in 2005 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | - |
Kenota Health, Inc.
 Kenota Health, Inc. Medical SpecialtiesHealth Technology Kenota Health, Inc. designs and develops medical diagnostic tools. The company was founded by Moufeed Kaddoura and Eric Bloudeel in 2014 and is headquartered in Kitchener, Canada. | Direktor/Vorstandsmitglied | 09.03.2022 |
Ehemalige bekannte Positionen von Dennis M. Flannelly
| Unternehmen | Position | Ende |
|---|---|---|
ReadCoor, Inc.
 ReadCoor, Inc. Internet Software/ServicesTechnology Services ReadCoor, Inc. operates sequencing platform. The firm develops Fluorescence In-situ Sequencing technology, which enables integration of high throughput sequencing, morphometric analysis, cellular location and three dimensional spatial imaging. The company was founded by Richard Terry, Marcell M. Shawn, Evan R. Daugharthy, and George M. Church in 2014 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Dennis M. Flannelly
| Villanova University | Undergraduate Degree |
| St. Joseph's University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Health Technology |
ReadCoor, Inc.
ReadCoor, Inc. Internet Software/ServicesTechnology Services ReadCoor, Inc. operates sequencing platform. The firm develops Fluorescence In-situ Sequencing technology, which enables integration of high throughput sequencing, morphometric analysis, cellular location and three dimensional spatial imaging. The company was founded by Richard Terry, Marcell M. Shawn, Evan R. Daugharthy, and George M. Church in 2014 and is headquartered in Cambridge, MA. | Technology Services |
Weavr Health Corp.
Weavr Health Corp. Medical DistributorsDistribution Services Boston MicroFluidics, Inc. manufactures medical devices. Its product is designed to measure, prepare, and transport blood samples. The company was founded in 2005 and is headquartered in Boston, MA. | Distribution Services |
Kenota Health, Inc.
Kenota Health, Inc. Medical SpecialtiesHealth Technology Kenota Health, Inc. designs and develops medical diagnostic tools. The company was founded by Moufeed Kaddoura and Eric Bloudeel in 2014 and is headquartered in Kitchener, Canada. | Health Technology |
